Active, not recruitingPhase 3NCT02375204

Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors

Studying Extragonadal germ cell tumor

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Alliance for Clinical Trials in Oncology
Principal Investigator: Darren Feldman, MD
Memorial Sloan Kettering Cancer Center
Intervention: paclitaxel(drug)
Enrollment: 420 enrolled
Eligibility: 14 years · MALE
Timeline: 2015 – 2031

Study locations (30)

Children's Hospital of Alabama, Birmingham, Alabama, United States
UC San Diego Moores Cancer Center, La Jolla, California, United States
Loma Linda University Medical Center, Loma Linda, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
Kaiser Permanente-Oakland, Oakland, California, United States
Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
UCSF Medical Center-Mission Bay, San Francisco, California, United States
Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
University of Florida Health Science Center - Gainesville, Gainesville, Florida, United States
Nemours Children's Clinic-Jacksonville, Jacksonville, Florida, United States
Nicklaus Children's Hospital, Miami, Florida, United States
Miami Cancer Institute, Miami, Florida, United States
Arnold Palmer Hospital for Children, Orlando, Florida, United States
Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
+15 more locations on ClinicalTrials.gov

Collaborators

National Cancer Institute (NCI) · European Organisation for Research and Treatment of Cancer - EORTC · Movember Foundation · Institute of Cancer Research (ICR), United Kingdom · Cancer Research UK · UNICANCER · Irish Group CTI

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02375204 on ClinicalTrials.gov

Other trials for Extragonadal germ cell tumor

Additional recruiting or active studies for the same condition.

See all trials for Extragonadal germ cell tumor →

← Back to all trials